Telehealth Boom Is Driving this Mental Health Company’s Progress
Telehealth services boomed during 2020, as patients stuck at home required safe access to vital services, and are expected to continue post-pandemic. Before the public health emergence, only 14,000 Medicare beneficiaries received telehealth services per ... [Read]
Psychedelic Decriminalization Creating Market Opportunities
What was once a war on drugs has turned into a public push for the decriminalization and legalization of illegal drugs with potential therapeutic benefits. Legalization efforts began with marijuana in 2018, creating a booming ... [Read]
Psychedelics Move to The Forefront of Innovative Research as the FDA Approves Large-Scale Testing
Psychedelics are quietly being used in clinical settings on small numbers of patients, but they are moving quickly toward medical approval. The FDA recently approved large-scale human trials to determine whether MDMA and other psychedelics ... [Read]
MNK Stock Tanks on DOJ Suit for Underpayment of Medicaid Rebates
MNK stock is sinking this week after it was reported that the US Department of Justice (DOJ) is suing Mallinckrodt (NYSE:MNK) for alleged underpayment of Medicaid rebates. The embattled pharmaceutical firm, which is currently involved ... [Read]
ASRT Stock Soars 52% on Asset Sale to Collegium for $375 Million
ASRT stock has been on a tearing rally this morning on the back of a significant announcement this morning. Big Development Assertio Therapeutics Inc (NASDAQ:ASRT) made an announcement with regards to a crucial asset sale, ... [Read]
AMRX Stock Soars as FDA Approves EluRyng: Next Steps
When it comes to significant movements in the stock price of a pharmaceutical company, then there are very few triggers that are better than that of positive development with regards to a product in the ... [Read]
MNK Stock Drops as Company Announces Opioid Crisis Oversight Report
MNK stock is trading down on Wednesday after Mallinckrodt (NYSE:MNK) announced plans to publish a report into the board’s oversight of risks related to the company’s role in contributing to the opioid crisis in the ... [Read]
MNK Stock Trades Near Low as Federal Opioid Probe Looms
MNK stock is currently trading near a low as US prosecutors open a criminal probe against opioid makers, of which Mallinckrodt (NYSE:MNK) is one of six major players. The Wall Street Journal first reported that ... [Read]
ADMP Stock Falls 50%: FDA Rejects Opioid Overdose Treatment Zimhi
ADMP is one of the biggest losers in the health sector on Monday after Adamis Pharmaceuticals Corp (NASDAQ:ADMP) said that the US Food and Drug Administration did not approve its opioid overdose treatment, Zimhi. Major ... [Read]
MNK Stock Sinks as Sales Fall Well Short of Expectations
MNK stock is down over 6% today after Mallinckrodt PLC (NYSE:MNK) reported its third-quarter earnings this week, with sales falling well short of analysts’ expectations. MNK Stock Trades Near All-Time Low The Irish tax-registered pharmaceutical ... [Read]